This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A phase I–II controlled randomized trial using a promising novel cell-free formulation for articular cartilage regeneration as treatment of severe osteoarthritis of the knee
European Journal of Medical Research Open Access 24 October 2018
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wong, P. C. et al. Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding. Sci. Transl Med. 9, eaaf5294 (2017)
Rights and permissions
About this article
Cite this article
Crunkhorn, S. Safe path to thrombosis prevention. Nat Rev Drug Discov 16, 164–165 (2017). https://doi.org/10.1038/nrd.2017.27
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.27
This article is cited by
-
A phase I–II controlled randomized trial using a promising novel cell-free formulation for articular cartilage regeneration as treatment of severe osteoarthritis of the knee
European Journal of Medical Research (2018)